MYC and hepatocellular carcinoma: The 1-, 3-, and 5-year DFS and OS rates (70.0%, 54.9%, 45.9% and 92.0%, 72.0%, 62.0%, respectively) in patients with HCC with high c-Myc expression were remarkably higher than those with low c-Myc expression (17.6%, 11.8%, 11.8% and 64.7%, 20.6%, 14.7%).